AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25050491 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 61
Study 22245487 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 10
Study 22245487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18996662 — intervention group
Group type: EXPERIMENTAL
Intervention: TEVAR (thoracic endovascular aortic repair)
Number of subjects: 88
Study 18996662 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 88
Study 18269128 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting (sand) with Al2O3 50 microm
Number of subjects: 0
Study 18269128 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroform (CHCl3) treatment
Number of subjects: 0
Study 18269128 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 18269128 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroform (CHCl3) + Silane (sil) treatment
Number of subjects: 0
Study 18269128 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting (sand) + Silane (sil) treatment
Number of subjects: 0
Study 18269128 — intervention group
Group type: EXPERIMENTAL
Intervention: Silane (sil) treatment
Number of subjects: 0
Study 15649877 — intervention group
Group type: COMPARATOR
Intervention: Side motion tests
Number of subjects: 9
Study 15649877 — intervention group
Group type: COMPARATOR
Intervention: Head-up tilt tests
Number of subjects: 9
Study 15649877 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous arousals
Number of subjects: 9
Study 15649877 — intervention group
Group type: COMPARATOR
Intervention: HR variability during slow-wave sleep (SWS)
Number of subjects: 9
Study 12191661 — intervention group
Group type: COMPARATOR
Intervention: All Bond 2 with C & B (Bisco)
Number of subjects: 50
Study 12191661 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond Multipurpose Plus with Opal Luting Composite (3M)
Number of subjects: 50
Study 12191661 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond 1 in combination with Rely X ARC resin cement (3M)
Number of subjects: 50
Study 12191661 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐step with C & B resin cement (Bisco)
Number of subjects: 50
Study 12191661 — intervention group
Group type: EXPERIMENTAL
Intervention: All Bond Experimental with Post Cement HI‐X (Bisco)
Number of subjects: 50
Study 9809626 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (3 x 10(6)U)
Number of subjects: 24
Study 9809626 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 24
Study 7715295 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 14
Study 7715295 — intervention group
Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 14
Study 7715295 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study 2720328 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-knee graduated compression stockings
Number of subjects: 114
Study 2720328 — intervention group
Group type: COMPARATOR
Intervention: Below-knee graduated compression stockings
Number of subjects: 114
Study 1087955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine isethionate
Number of subjects: 21
Study 1087955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulfadiazine
Number of subjects: 21
Study 1087955 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both regimens
Number of subjects: 21
Study 7426275 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 4
Study 7426275 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐methyl digoxin (medigoxin)
Number of subjects: 4
Study 7426275 — intervention group
Group type: COMPARATOR
Intervention: Ouabain
Number of subjects: 4
Study 31623611 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed red meat with high drinking water nitrate (3.7 mg/kg bodyweight)
Number of subjects: 20
Study 31623611 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprocessed white meat with high drinking water nitrate (3.7 mg/kg bodyweight)
Number of subjects: 20
Study 31623611 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed red meat
Number of subjects: 20
Study 31623611 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprocessed white meat
Number of subjects: 20
Study 28705539 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate instillation of mitomycin C (MMC) within 24 hours after TURBT
Number of subjects: 2243
Study 28705539 — intervention group
Group type: COMPARATOR
Intervention: Delayed instillation of mitomycin C (MMC) 2 weeks after TURBT
Number of subjects: 2243
Study 28705539 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate instillation of mitomycin C (MMC)
Number of subjects: 2243
Study 28705539 — intervention group
Group type: COMPARATOR
Intervention: Delayed instillation of mitomycin C (MMC)
Number of subjects: 2243
Study 27654259 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (conventional antidiabetic doses)
Number of subjects: 60
Study 27654259 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 healthy donors)
Number of subjects: 60
Study 24463451 — intervention group
Group type: EXPERIMENTAL
Intervention: teriparatide (20 μg recombinant human parathyroid hormone)
Number of subjects: 79
Study 24463451 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 79
Study 24463451 — intervention group
Group type: EXPERIMENTAL
Intervention: teriparatide
Number of subjects: 79
Study 22340202 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest ultrasound (US)
Number of subjects: 98
Study 20719253 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 μg twice daily for 12 months
Number of subjects: 202
Study 20719253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 17926437 — intervention group
Group type: EXPERIMENTAL
Intervention: High-efficacy condition
Number of subjects: 28
Study 17926437 — intervention group
Group type: COMPARATOR
Intervention: Low-efficacy condition
Number of subjects: 28
Study 17926437 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity cycling session
Number of subjects: 28
Study 16170180 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT); concurrent cisplatin (25 mg/m2 on days 1 to 4) on weeks 1, 4, and 7 of RT and adjuvant cisplatin (20 mg/m2 on days 1 to 4) and fluorouracil (1,000 mg/m2 on days 1 to 4) every 4 weeks for three cycles after completion of RT
Number of subjects: 221
Study 16170180 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone; 70 Gy in 7 weeks
Number of subjects: 221
Study 11948051 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 32
Study 11948051 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 9568915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical information collected from parents regarding the progression of Canavan disease.
Number of subjects: 60
Study 9568915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical information collected from parents regarding the clinical course of Canavan disease.
Number of subjects: 60
Study 7613554 — intervention group
Group type: EXPERIMENTAL
Intervention: Moguisteine (100 mg t.i.d.)
Number of subjects: 119
Study 7613554 — intervention group
Group type: COMPARATOR
Intervention: Codeine 15 mg (t.i.d.)
Number of subjects: 119
Study 7613554 — intervention group
Group type: COMPARATOR
Intervention: Codeine 30 mg (t.i.d.)
Number of subjects: 119
Study 2387517 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental stents without side holes
Number of subjects: 40
Study 2387517 — intervention group
Group type: COMPARATOR
Intervention: Conventional stents
Number of subjects: 40
Study 576296 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant intravenous infusion of regular insulin (2 units/hour)
Number of subjects: 8
Study 576296 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin (two thirds of daily maintenance doses)
Number of subjects: 8
Study 576296 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative NPH insulin and 1 unit/hour insulin administration
Number of subjects: 8
Study 31804876 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance after R-CHOP
Number of subjects: 560
Study 31804876 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance after R-FC
Number of subjects: 560
Study 31804876 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 560
Study 31804876 — intervention group
Group type: COMPARATOR
Intervention: R-FC
Number of subjects: 560
Study 31804876 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance
Number of subjects: 560
Study 29209926 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic phenylephrine infusion (50 μg·min‐1, titrated)
Number of subjects: 160
Study 29209926 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine bolus dosing (100 μg)
Number of subjects: 160
Study 26742011 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-endorsed invitation letter
Number of subjects: 265434
Study 26742011 — intervention group
Group type: COMPARATOR
Intervention: Standard invitation letter
Number of subjects: 265434
Study 26742011 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of GPE
Number of subjects: 265434
Study 26742011 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of standard invitation
Number of subjects: 265434
Study 24048950 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of irbesartan 300 mg film-coated tablet
Number of subjects: 40
Study 23649068 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid + single bond + sealant (Group 2)
Number of subjects: 60
Study 23649068 — intervention group
Group type: EXPERIMENTAL
Intervention: Protect bond + sealant (Group 6)
Number of subjects: 60
Study 23649068 — intervention group
Group type: COMPARATOR
Intervention: S (3) bond + sealant (Group 4)
Number of subjects: 60
Study 23649068 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid + saliva + single bond + sealant (Group 1)
Number of subjects: 60
Study 23649068 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva + S (3) bond + sealant (Group 3)
Number of subjects: 60
Study 23649068 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva + protect bond + sealant (Group 5)
Number of subjects: 60
Study 20845670 — intervention group
Group type: EXPERIMENTAL
Intervention: General inhalational anesthesia with sevoflurane (group S)
Number of subjects: 45
Study 20845670 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol (group T)
Number of subjects: 45
Study 20845670 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia (group R)
Number of subjects: 45
Study 18219299 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (LS; 50 mmol Na(+)/24 h)
Number of subjects: 34
Study 18219299 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium diet (HS; 200 mmol Na(+)/24 h)
Number of subjects: 34
Study 18219299 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium diet with ACE inhibitor (HS-ACEi; enalapril 20 mg/day)
Number of subjects: 34
Study 16014874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive discharge planning services and community-based case management services
Number of subjects: 1400
Study 16014874 — intervention group
Group type: COMPARATOR
Intervention: Less-intensive discharge planning and no community-based services
Number of subjects: 1400
Study 12664021 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in peanut oil
Number of subjects: 81
Study 12664021 — intervention group
Group type: COMPARATOR
Intervention: Vehicle oil alone
Number of subjects: 81
Study 10758845 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n = 28)
Number of subjects: 56
Study 10758845 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 56
Study 8694217 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine 2 ml with 1:200,000 adrenaline
Number of subjects: 36
Study 8694217 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 2 ml
Number of subjects: 36
Study 1398272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel (0.5 mg)
Number of subjects: 165
Study 1398272 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 165
Study 4025314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine heparin #1
Number of subjects: 40
Study 4025314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine heparin #2
Number of subjects: 40
Study 4025314 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine gut heparin
Number of subjects: 40
Study 4025314 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 40
Study 29754671 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 6500
Study 29754671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6500
Study 27037227 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training (AET)
Number of subjects: 31
Study 27037227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 31
Study 27037227 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 31
Study 25134225 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants' health care charges
Number of subjects: 139
Study 25134225 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants' morbidity
Number of subjects: 139
Study 25134225 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-baby clinic visit
Number of subjects: 139
Study 21194762 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose tirofiban
Number of subjects: 1398
Study 21194762 — intervention group
Group type: COMPARATOR
Intervention: Bleeding
Number of subjects: 1398
Study 20370419 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+SDD
Number of subjects: 41
Study 20370419 — intervention group
Group type: COMPARATOR
Intervention: SRP+placebo
Number of subjects: 41
Study 18236729 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative strategy (fluid restriction)
Number of subjects: 1000
Study 18236729 — intervention group
Group type: COMPARATOR
Intervention: Liberal strategy (fluid intake)
Number of subjects: 1000
Study 15892438 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic health-related instruments administered first (SF-36 followed by HADS)
Number of subjects: 1015
Study 15892438 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision-targeted instruments administered first (NEI-VFQ followed by SST-VPVS)
Number of subjects: 1015
Study 12684289 — intervention group
Group type: EXPERIMENTAL
Intervention: BPV plus conventional therapy
Number of subjects: 30
Study 12684289 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone (Control)
Number of subjects: 30
Study 10098826 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of generalized anxiety, panic, and dysthymic disorders
Number of subjects: 181
Study 10098826 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochondriacal personality disorder
Number of subjects: 181
Study 10098826 — intervention group
Group type: COMPARATOR
Intervention: Other personality disorders
Number of subjects: 181
Study 9345409 — intervention group
Group type: EXPERIMENTAL
Intervention: Copolymer I (20 mg daily subcutaneous injection)
Number of subjects: 251
Study 9345409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 2050174 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual captopril (25 mg)
Number of subjects: 8
Study 2050174 — intervention group
Group type: COMPARATOR
Intervention: Peroral captopril (25 mg)
Number of subjects: 8
Study 6410442 — intervention group
Group type: EXPERIMENTAL
Intervention: flurazepam (30 mg)
Number of subjects: 96
Study 6410442 — intervention group
Group type: EXPERIMENTAL
Intervention: tryptophan (1 g)
Number of subjects: 96
Study 6410442 — intervention group
Group type: EXPERIMENTAL
Intervention: secobarbital (100 mg)
Number of subjects: 96
Study 6410442 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 96
Study 31010449 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated, exposure-based treatment (COPE)
Number of subjects: 71
Study 31010449 — intervention group
Group type: COMPARATOR
Intervention: Non-exposure-based, SUD-only treatment (RP)
Number of subjects: 71
Study 30947686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care group
Number of subjects: 106
Study 30947686 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 106
Study 30947686 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study 30947686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care participants
Number of subjects: 106
Study 30428858 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake meeting Children's Food Trust (CFT) guidelines
Number of subjects: 150
Study 30428858 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA)
Number of subjects: 150
Study 30428858 — intervention group
Group type: EXPERIMENTAL
Intervention: Minutes spent in light PA
Number of subjects: 150
Study 30428858 — intervention group
Group type: EXPERIMENTAL
Intervention: Active time
Number of subjects: 150
Study 27028980 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg/d, up-titrated to 30 mg/d)
Number of subjects: 58
Study 27028980 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 58
Study 27028980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 24690571 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral perfusion pressure-targeted therapy (n = 55)
Number of subjects: 110
Study 24690571 — intervention group
Group type: COMPARATOR
Intervention: Intracranial pressure-targeted therapy (n = 55)
Number of subjects: 110
Study 22240353 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg RES capsule daily for 3 months
Number of subjects: 40
Study 22240353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20375811 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotically assisted laparoscopic radical hysterectomy
Number of subjects: 60
Study 20375811 — intervention group
Group type: COMPARATOR
Intervention: Open radical hysterectomy
Number of subjects: 60
Study 17549295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose HT (1 mg 17ss-oestradiol + 0.5 mg norethisterone acetate) (n = 50)
Number of subjects: 202
Study 17549295 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-dose HT (2 mg 17ss-oestradiol and 1 mg NETA) (n = 50)
Number of subjects: 202
Study 17549295 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg) (n = 51)
Number of subjects: 202
Study 17549295 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg) (n = 51)
Number of subjects: 202
Study 15333616 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental exercise test to exhaustion on a treadmill
Number of subjects: 300
Study 15333616 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 300
Study 12123487 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil (600 mg twice daily)
Number of subjects: 65
Study 12123487 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study 9863873 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy arms (zidovudine, zalcitabine, didanosine)
Number of subjects: 722
Study 9863873 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies (zidovudine, zalcitabine, didanosine)
Number of subjects: 722
Study 9863873 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence assessment
Number of subjects: 722
Study 9863873 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall non-adherence behaviors
Number of subjects: 722
Study 8568176 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterosonography with sterile saline injection using a novel catheter
Number of subjects: 220
Study 1636617 — intervention group
Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acids (MUFAs)
Number of subjects: 17
Study 1636617 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO) diet
Number of subjects: 17
Study 6201083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran infusion with hapten blockade (monovalent dextran-1)
Number of subjects: 116
Study 6201083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran infusion
Number of subjects: 116
Study 31996363 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA
Number of subjects: 60
Study 31996363 — intervention group
Group type: COMPARATOR
Intervention: APR
Number of subjects: 60
Study 31479306 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 0
Study 31479306 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (25 mg/day)
Number of subjects: 0
Study 31479306 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 0
Study 31479306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 0
Study 31479306 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tamoxifen
Number of subjects: 0
Study 29849453 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart nebulization
Number of subjects: 65
Study 29849453 — intervention group
Group type: COMPARATOR
Intervention: Conventional nebulization
Number of subjects: 65
Study 26946734 — intervention group
Group type: EXPERIMENTAL
Intervention: Twirling reinforcing manipulation
Number of subjects: 126
Study 26946734 — intervention group
Group type: COMPARATOR
Intervention: Mild reinforcing-reducing manipulation
Number of subjects: 126
Study 26946734 — intervention group
Group type: COMPARATOR
Intervention: Twirling reducing manipulation
Number of subjects: 126
Study 24597764 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogeneic collagen matrix (CM)
Number of subjects: 30
Study 24597764 — intervention group
Group type: COMPARATOR
Intervention: Free gingival graft (FGG)
Number of subjects: 30
Study 22015574 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Planning (AP) program
Number of subjects: 0
Study 22015574 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Planning plus (AP+) program
Number of subjects: 0